Alaunos Therapeutics (TCRT) Preferred Dividend Payments (2016 - 2018)

Alaunos Therapeutics has reported Preferred Dividend Payments for 3 years, with the latest figure at $342000.0 in Q4 2018.

• For the quarter ending Q4 2018, Preferred Dividend Payments fell 93.16% year-over-year to $342000.0; the trailing twelve-month figure through Dec 2018 stood at $17.0 million (down 10.24% YoY), and the FY2018 full-year result was $17.0 million, down 10.24% from the prior year.
• Preferred Dividend Payments for Q4 2018 stood at $342000.0, down from $6.1 million in the prior quarter.
• The five-year high for Preferred Dividend Payments was $6.1 million in Q3 2018, with the low at $342000.0 in Q4 2018.
• Historically, Preferred Dividend Payments has averaged $4.3 million across 3 years, with a median of $4.9 million in 2017.
• Annual changes were most pronounced in 2017 — Preferred Dividend Payments jumped 41.53% — and 2018, when it sank 93.16%.
• Alaunos Therapeutics' Preferred Dividend Payments stood at $3.5 million in 2016, then soared by 41.53% to $5.0 million in 2017, then slumped by 93.16% to $342000.0 in 2018.
• The last three Preferred Dividend Payments figures came in at $342000.0 (Q4 2018), $6.1 million (Q3 2018), and $5.5 million (Q2 2018), per Business Quant data.